Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 17:03, 4 February 2021

25,902 bytes added ,  17:03, 4 February 2021
m
Reverted edits by FQuintero (talk) to last revision by Malini.Sathanoori
Line 1: Line 1:     +
{| class="wikitable"
 +
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
 +
|-
 +
!'''Disease'''!!'''Page Type'''!!'''Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''!!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 +
|
 +
|
 +
|complete
 +
|
 +
|Fabiola Quintero-Rivera (FQR)
 +
|
 +
|
 +
|-
 +
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
 +
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 +
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Polycythaemia Vera  (PV)||Disease
 +
|Gokce A. Toruner
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Primary Myelofibrosis  (PMF)||Disease
 +
|T. Niroshi  Senaratne
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|8/4/2020 before submission
 +
|
 +
|-
 +
|    Essential  Thrombocythaemia (ET)||Disease
 +
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
 +
|
 +
|
 +
|complete/pending faculty review
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 +
|(trainee), Daynna J.Wolff
 +
|
 +
|
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 +
|Thomas Lee
 +
|8/17/2020
 +
|9/7/2020
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
 +
|
 +
|
 +
|complete
 +
| ||FQR
 +
|
 +
|
 +
|-
 +
|    Cutaneous  Mastocytosis||Disease
 +
|Thuy Phung
 +
|
 +
|9/1/20
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Systemic Mastocytosis||Disease
 +
|Shashi Shetty
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Mast Cell Sarcoma||Disease
 +
|Thuy Phung +Jordan Lowery
 +
|
 +
|9/1/20
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
 +
|Disease
 +
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|NON-WHO ENTITY
 +
|-
 +
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
 +
|Disease
 +
|Lauren R. Crowson (trainee) + Daynna J. Wolff
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|NON-WHO ENTITY
 +
|-
 +
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 +
|
 +
|9/1/20
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
 +
|
 +
|9/1/20
 +
|pending
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 +
|
 +
|9/1/20
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 +
|
 +
|9/1/20
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 +
|
 +
|9/1/20
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 +
|
 +
|Complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 +
|
 +
|complete
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 +
|
 +
|9/1/20
 +
|PENDING
 +
|
 +
|FQR
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 +
|
 +
|
 +
|Complete
 +
|
 +
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 +
|
 +
|
 +
|-
 +
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|01/19/2021-MS (re-review)
 +
|
 +
|-
 +
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
 +
|
 +
|
 +
|PENDING
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|02/01/2021-MS
 +
|
 +
|-
 +
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
 +
|
 +
|
 +
|Complete
 +
|02/03/2021||JH / MS
 +
|
 +
|
 +
|-
 +
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|02/03/2021-MS
 +
|
 +
|-
 +
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|02/01/2021-MS (re-review)
 +
|
 +
|-
 +
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 +
|
 +
|
 +
|Complete
 +
|
 +
|JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|Need permission for figure?  Update WHO?
 +
|-
 +
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|Add WHO reference
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|Check reference format
 +
|-
 +
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|Need permission for figure?
 +
|-
 +
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|Check reference format
 +
|-
 +
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
 +
|
 +
|
 +
|PENDING
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
 +
|
 +
|
 +
|PENDING
 +
| ||JH / MS
 +
|
 +
|
 +
|-
 +
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
 +
|Disease
 +
|Kay Weng Choy + Greg Conboy (Monash Health)
 +
|
 +
|
 +
|Complete
 +
|
 +
|JH / MS
 +
|
 +
|NON-WHO ENTITY
 +
|-
 +
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
 +
|Disease
 +
|Daynna Wolff+Jessica Snider (Path Resident)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|JH / MS
 +
|
 +
|NON-WHO ENTITY
 +
|-
 +
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
 +
|Disease
 +
|Daynna Wolff+ Paige Woodham (Path Resident)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|JH / MS
 +
|
 +
|NON-WHO ENTITY
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||Yassmine Akkari (YA)
 +
|
 +
|
 +
|-
 +
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
 +
|
 +
|
 +
|PENDING
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
 +
|
 +
|
 +
|PENDING
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
 +
|
 +
|
 +
|PENDING
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
 +
 +
Lisa Smith + Yassmine Akkari
 +
|
 +
|
 +
|Complete
 +
|
 +
|YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
 +
|
 +
|
 +
|PENDING
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
 +
|
 +
|
 +
|PENDING
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 +
|
 +
|YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
 +
|
 +
|
 +
|PENDING
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
 +
|
 +
|
 +
|
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
 +
|
 +
|
 +
|
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||YA
 +
|
 +
|
 +
|-
 +
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
 +
|Disease
 +
|Helene Bruyere
 +
|
 +
|
 +
|PENDING
 +
|
 +
|YA
 +
|
 +
|NON-WHO ENTITY
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||Snehal Patel (SP)
 +
|
 +
|
 +
|-
 +
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|       Monoclonal B-cell  Lymphocytosis||Disease||Snehal Patel
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|B-cell Prolymphocytic Leukemia||Disease||Snehal Patel
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 +
|
 +
|
 +
|Complete
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Hairy Cell Leukemia||Disease||Snehal Patel
 +
|
 +
|
 +
|Complete
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 +
|
 +
|
 +
|Complete
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 +
|
 +
|
 +
|Complete
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 +
|
 +
|
 +
|Complete
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Lymphoplasmacytic Lymphoma||Disease||Snehal Patel
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|   Waldenstrom  Macroglobulinemia||Disease||Snehal Patel
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Mu Heavy Chain  Disease||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Alpha Heavy Chain  Disease||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Plasma Cell Neoplasms||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||
 +
|
 +
|
 +
|
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Plasma Cell Myeloma  Variants||Disease||Fariborz Rashid-Kolvear
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Plasmacytoma||Disease||
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|           Primary  Amyloidosis||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|         POEMS Syndrome||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|         TEMPI Syndrome||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||
 +
|
 +
|
 +
|
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 +
|
 +
|
 +
|Complete
 +
|11/11/2020
 +
|SP
 +
|
 +
|
 +
|-
 +
|Follicular Lymphoma||Disease||Ruthann Pfau
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 +
|
 +
|
 +
|Complete
 +
|8/16/2020
 +
|SP
 +
|
 +
|
 +
|-
 +
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
 +
|
 +
|9/30/20
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 +
|
 +
|8/15/20
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    In Situ Mantle Cell  Neoplasia||Disease||
 +
|
 +
|
 +
|
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 +
|
 +
|
 +
|PENDING
 +
|
 +
|Greg Corboy (GC)
 +
|
 +
|
 +
|-
 +
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|EBV-Positive Mucocutaneous Ulcer||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Lymphomatoid Granulomatosis||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Intravascular Large B-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|ALK-Positive Large B-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 +
|
 +
|
 +
|Complete
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Primary Effusion Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|   Multicentric Castleman  Disease||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Burkitt Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||GC
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||Snehal Patel (SP)
 +
|
 +
|
 +
|-
 +
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Aggressive NK-cell Leukemia||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Severe Mosquito Bite  Allergy||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Adult T-cell Leukemia/Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 +
|
 +
|Complete
 +
|1/21/2021
 +
|SP
 +
|
 +
|
 +
|-
 +
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
 +
|
 +
|
 +
|Complete
 +
|1/21/2021
 +
|SP
 +
|
 +
|
 +
|-
 +
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Lymphomatoid  Papulosis||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
 +
|
 +
|
 +
|PENDING
 +
| ||SP
 +
|
 +
|
 +
|-
 +
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 +
|
 +
|
 +
|PENDING
 +
|
 +
|SP
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||Associate Editor??
 +
|
 +
|
 +
|-
 +
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Lymphomas Associated with HIV Infection||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 +
 +
Fabiola Quintero-Rivera
 +
|
 +
|
 +
|PENDING
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|          Monomorphic  B-cell PTLD||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|          Monomorphic  T/NK-cell PTLD||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Histiocytic Sarcoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|   Langerhans Cell  Histiocytosis||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|   Langerhans Cell  Sarcoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Indeterminate Dendritic Cell Tumour||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Interdigitating Dendritic Cell Sarcoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Follicular Dendritic Cell Sarcoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Fibroblastic Reticular Cell Tumor||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Disseminated Juvenile Xanthogranuloma||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
|Erdheim-Chester Disease||Disease||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|-
 +
| || ||
 +
|
 +
|
 +
|
 +
| ||
 +
|
 +
|
 +
|}
 
{| class="wikitable sortable"
 
{| class="wikitable sortable"
 
|+Gene-Specific Pages
 
|+Gene-Specific Pages
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/9560"